Loading clinical trials...
Loading clinical trials...
Development of a Just-in-Time Adaptive Intervention to Reduce High-Intensity Drinking Among Young Adults
This study aims to examine the feasibility and acceptability of a mobile health intervention to reduce alcohol use and related consequences among young adults. Participants will be randomly assigned to either receive access to the mobile health intervention or receive only generic study surveys. Participants will receive text message surveys sent to their personal cellphone for 4 weeks per their assigned trial arm. All participants will receive a post-survey 30 days after their final weekly survey text.
This study aims to determine whether a mobile health intervention to reduce alcohol use and related consequences is acceptable and feasible among young adults who engage in high-intensity drinking (HID; 8+/10+ drinks per drinking occasion for females/males, respectively). The investigators aim to recruit 40 adults between 18-25 years of age who report at least one HID episode in the past 30 days. After providing informed consent, participants will be randomly assigned to receive the mobile health intervention or control surveys only. Participants will attend one online study visit to enroll in the study and be assigned to their study arm. All subsequent study activities will be completed asynchronously. Participants will then receive text message prompts and/or surveys to their personal cellphone either Wednesday or Thursday through Sunday for four consecutive weeks. Participants will receive a post-test survey 30 days after their final weekly survey.
Age
18 - 25 years
Sex
ALL
Healthy Volunteers
No
Rosenau Hall
Chapel Hill, North Carolina, United States
Start Date
September 29, 2025
Primary Completion Date
January 6, 2026
Completion Date
January 6, 2026
Last Updated
January 21, 2026
40
ACTUAL participants
Mobile Health Intervention to Reduce Alcohol Use Among Young Adults
BEHAVIORAL
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
NCT06778278
NCT05555264
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07444359